The Rare Disease Frontier: Understanding the Fabry Disease Market
The Fabry Disease Market is a vital and rapidly evolving segment of the global pharmaceutical industry, dedicated to addressing a rare genetic disorder with significant unmet medical needs. Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of the enzyme alpha-galactosidase A, leading to the accumulation of harmful substances in cells throughout the body....
0 Commentaires 0 Parts 154 Vue 0 Aperçu